In NKTCL, a constructed human anti-LMP1 antibody successfully inhibited cell proliferation, induced apoptosis and activated antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity at least partly via inhibiting JAK3/STAT3 [119]. This evidence concerns the gene PDLIM7 and extranodal nasal NK/T cell lymphoma.